Health
How Moderna execs are cashing in on COVID-19 vaccine stock speculation – CNA
Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage company’s value could crash.
REUTERS: Biotech firm Moderna Inc could reap tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If it loses, the early-stage companys value could …
Continue Reading
-
General13 hours ago‘Enrolment crisis’ for performing arts students at Virtual School Victoria
-
Noosa News13 hours agoLack of health care looms large in minds of ageing rural Australians
-
Noosa News16 hours agoHow Youtuber Louis Rossmann’s beef with an Australian PlayStation repair whiz revealed a shocking past
-
General10 hours agoNonagenarians have remained friends for more than 40 years